Based on the statistics of the Department of Health (DOH) there is a constant growth of the mortality rate of CVD patients, whereas, from 1990 to 2000 the mortality rate of CVD is 74.6%-79.1%.
Thirty- and 60-day STO rates were slightly higher for non-participants but not statistically significant.
One hundred eighty-day STO rates were statistically higher for participants than non-participants (p = .027).
In our experiments we demonstrate that performance both in outcome prediction and monitoring is better when the analysis is based on combined rather than one-dimensional features.
We also propose and experimentally verify methods firstly to control performance and secondly to ensure that performance results are reliable. The precordial compressions and ventilations cause artefacts in the ECG so that treatment has to be stopped during analysis.